Biotechnology
ANL
1.82
price down icon8.77%   -0.175
after-market Handel nachbörslich: 1.82

Adlai Nortye Ltd Adr (ANL)
full-star
loading
Überblick Nachrichten Preisverlauf Forum Prognose
Schlusskurs vom Vortag:
$1.995
Offen:
$1.78
24-Stunden-Volumen:
83,940
Relative Volume:
5.83
Marktkapitalisierung:
$170.55M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-0.7223
EPS:
-2.5197
Netto-Cashflow:
-
1W Leistung:
-1.62%
1M Leistung:
-8.08%
6M Leistung:
-18.39%
1J Leistung:
-76.36%
1-Tages-Spanne:
Value
$1.78
$1.96
1-Wochen-Bereich:
Value
$1.78
$2.10
52-Wochen-Spanne:
Value
$1.10
$8.37

Adlai Nortye Ltd Adr Stock (ANL) Company Profile

Name
Firmenname
Adlai Nortye Ltd Adr
Name
Sektor
Healthcare (1170)
Name
Branche
Biotechnology (667)
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
123
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
ANL's Discussions on Twitter

Vergleichen Sie ANL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ANL
Adlai Nortye Ltd Adr
 1.82 68.27M 0 0 0 0.00
Biotechnology icon
ONC
Beone Medicines Ltd Adr
 245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
 1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
 81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 490.28 63.52B 14.09B 4.50B 2.96B 39.28

Adlai Nortye Ltd Adr Stock (ANL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-09-04 Eingeleitet H.C. Wainwright Buy
2023-10-24 Eingeleitet Cantor Fitzgerald Overweight

Adlai Nortye Ltd Adr Aktie (ANL) Neueste Nachrichten

pulisher
May 30, 2025

Adlai Nortye Discontinues Buparlisib Development After Phase III Trial Results - TipRanks

May 30, 2025
pulisher
Apr 17, 2025

ANL stock touches 52-week low at $1.71 amid sharp annual decline - Investing.com India

Apr 17, 2025
pulisher
Apr 17, 2025

ANL stock touches 52-week low at $1.71 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 17, 2025
pulisher
Apr 07, 2025

ANL stock touches 52-week low at $1.85 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

ANL stock touches 52-week low at $1.85 amid sharp annual decline - Investing.com India

Apr 07, 2025
pulisher
Mar 28, 2025

Adlai Nortye stock hits 52-week low at $1.85 amid sharp decline By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Adlai Nortye stock hits 52-week low at $1.85 amid sharp decline - Investing.com India

Mar 28, 2025
pulisher
Feb 14, 2025

Adlai Nortye Announces Change in Auditing Firm - TipRanks

Feb 14, 2025
pulisher
Dec 31, 2024

Adlai Nortye Announces CFO Transition with Interim Appointment - TipRanks

Dec 31, 2024
pulisher
Nov 19, 2024

Trump Announces Nomination of Howard Lutnick to Serve as US Commerce Secretary, to Run Office of US Trade Representative - AASTOCKS.com

Nov 19, 2024
pulisher
Sep 29, 2023

Adlai Nortye (ANL) Stock Price, News & Analysis - MarketBeat

Sep 29, 2023
pulisher
Sep 29, 2023

Adlai Nortye IPO gives old Novartis cancer drug new life - BioPharma Dive

Sep 29, 2023
pulisher
Aug 17, 2023

CRVO Stock Quote Price and Forecast - CNN

Aug 17, 2023

Finanzdaten der Adlai Nortye Ltd Adr-Aktie (ANL)

Es liegen keine Finanzdaten für Adlai Nortye Ltd Adr (ANL) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ähnlich wie ANL

biotechnology BDRX
$1.08
price up icon 1.89%
biotechnology ZLAB
$30.14
price down icon 3.74%
biotechnology ARGX
$573.26
price down icon 1.32%
biotechnology ALNY
$304.56
price up icon 3.98%
biotechnology ATHE
$4.50
price down icon 3.02%
biotechnology REGN
$490.28
price down icon 19.01%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters
Kapitalisierung:     |  Volumen (24h):